Literature DB >> 15821813

Obstructive jaundice secondary to bile duct involvement with Hodgkin's disease: a case report.

Veruska Di Sena1, Fernanda Prata Borges Martins Thuler, Erika Pereira Macedo, Gustavo Andrade de Paulo, Ermelindo Della Libera, Angelo Paulo Ferrari.   

Abstract

CONTEXT: Obstructive jaundice due to lymphoma is very rare. It may be difficult to distinguish between this condition and a large number of causes of extrahepatic bile duct obstruction, even by endoscopic retrograde cholangiography. Its prognosis is poor. Combined chemotherapy and/or radiotherapy with bile duct drainage is a therapeutic option. CASE REPORT: We describe a case of obstructive jaundice as the initial presentation of Hodgkin's disease. After chemotherapy and endoscopic bile duct stenting, it was noted that the enlarged lymph nodes, jaundice and bile duct dilation disappeared.

Entities:  

Mesh:

Year:  2005        PMID: 15821813     DOI: 10.1590/s1516-31802005000100007

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  4 in total

1.  Biliary tract obstruction secondary to malignant lymphoma: experience at a referral center.

Authors:  Bülent Odemiş; Erkan Parlak; Omer Başar; Osman Yüksel; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

Review 2.  Primary Hodgkin's disease of the common bile duct: a case report and review of literature.

Authors:  Jyoti Sharma; Pankaj Kumar Garg; Deepali Jain; Sameer Bakshi; Durgatosh Pandey
Journal:  J Gastrointest Cancer       Date:  2014-12

Review 3.  Management of Malignant Biliary Obstruction.

Authors:  Jonathan M Lorenz
Journal:  Semin Intervent Radiol       Date:  2016-12       Impact factor: 1.513

4.  Cutaneous Large B Cell Lymphoma Involving the Duodenum and the Bile Duct: a Case Report.

Authors:  Lamine Hamzaoui; Mouna Medhioub; Amal Khsiba; Moufida Mahmoudi; Talel Badri; Mohamed Msaddak Azouz
Journal:  J Gastrointest Cancer       Date:  2019-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.